These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 29580896)

  • 41. The Warburg Effect: Historical Dogma Versus Current Rationale.
    Vaupel P; Multhoff G
    Adv Exp Med Biol; 2021; 1269():169-177. PubMed ID: 33966213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging Roles of p53 Family Members in Glucose Metabolism.
    Itahana Y; Itahana K
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer.
    Yalcin A; Telang S; Clem B; Chesney J
    Exp Mol Pathol; 2009 Jun; 86(3):174-9. PubMed ID: 19454274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
    Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
    Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.
    Allison KE; Coomber BL; Bridle BW
    Immunology; 2017 Oct; 152(2):175-184. PubMed ID: 28621843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?
    López-Lázaro M
    Anticancer Agents Med Chem; 2008 Apr; 8(3):305-12. PubMed ID: 18393789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery.
    Talekar M; Boreddy SR; Singh A; Amiji M
    Expert Opin Biol Ther; 2014 Aug; 14(8):1145-59. PubMed ID: 24762115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pimozide inhibits the growth of breast cancer cells by alleviating the Warburg effect through the P53 signaling pathway.
    Li J; Qu P; Zhou XZ; Ji YX; Yuan S; Liu SP; Zhang QG
    Biomed Pharmacother; 2022 Jun; 150():113063. PubMed ID: 35658233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
    Parajuli P; Tiwari RV; Sylvester PW
    Biol Pharm Bull; 2015; 38(9):1352-60. PubMed ID: 26328490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Post-translational modifications and the Warburg effect.
    Hitosugi T; Chen J
    Oncogene; 2014 Aug; 33(34):4279-85. PubMed ID: 24096483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting metabolic dependencies in pediatric cancer.
    Issaq SH; Heske CM
    Curr Opin Pediatr; 2020 Feb; 32(1):26-34. PubMed ID: 31789976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Promising strategy developed to target drug-resistant cancer cells.
    Thorne J
    Future Med Chem; 2014 Apr; 6(6):603. PubMed ID: 25028759
    [No Abstract]   [Full Text] [Related]  

  • 53. The sweet trap in tumors: aerobic glycolysis and potential targets for therapy.
    Yu L; Chen X; Wang L; Chen S
    Oncotarget; 2016 Jun; 7(25):38908-38926. PubMed ID: 26918353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic alterations in cancer cells and therapeutic implications.
    Hammoudi N; Ahmed KB; Garcia-Prieto C; Huang P
    Chin J Cancer; 2011 Aug; 30(8):508-25. PubMed ID: 21801600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic reprogramming in triple-negative breast cancer.
    Wang Z; Jiang Q; Dong C
    Cancer Biol Med; 2020 Feb; 17(1):44-59. PubMed ID: 32296576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxidative phosphorylation as a target to arrest malignant neoplasias.
    Rodríguez-Enríquez S; Gallardo-Pérez JC; Marín-Hernández A; Aguilar-Ponce JL; Mandujano-Tinoco EA; Meneses A; Moreno-Sánchez R
    Curr Med Chem; 2011; 18(21):3156-67. PubMed ID: 21671858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
    Li C; Zhang G; Zhao L; Ma Z; Chen H
    World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Warburg meets non-coding RNAs: the emerging role of ncRNA in regulating the glucose metabolism of cancer cells.
    Yu C; Xue J; Zhu W; Jiao Y; Zhang S; Cao J
    Tumour Biol; 2015 Jan; 36(1):81-94. PubMed ID: 25431262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of AMP-activated protein kinase in cancer therapy.
    Rehman G; Shehzad A; Khan AL; Hamayun M
    Arch Pharm (Weinheim); 2014 Jul; 347(7):457-68. PubMed ID: 24677093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An update on therapeutic opportunities offered by cancer glycolytic metabolism.
    Granchi C; Fancelli D; Minutolo F
    Bioorg Med Chem Lett; 2014 Nov; 24(21):4915-25. PubMed ID: 25288186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.